Bernards Rene has filed 11 insider transactions across 1 company since October 2023.
Most recent transaction: a grant/award of 10000 shares of LIXTE BIOTECHNOLOGY HOLDINGS, INC. ($LIXT) on June 30, 2025.
Activity breakdown: 4 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 30, 2025 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Bernards Rene | Director | A | Options to Purchase Common Stock | 10000 | $0.00 | 41,664.0000 | 2,249,290 | 31.58% | 0.44% |
| June 30, 2025 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Bernards Rene | Director | A | Options to Purchase Common Stock | 10662 | $0.00 | 42,326.0000 | 2,249,290 | 33.67% | 0.47% |
| March 31, 2025 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Bernards Rene | Director | A | Options to Purchase Common Stock | 8045 | $0.00 | 31,664.0000 | 2,249,290 | 34.06% | 0.36% |
| Jan. 20, 2025 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Bernards Rene | Director | A | Options to Purchase Common Stock | 4166 | $0.00 | 23,619.0000 | 2,249,290 | 21.42% | 0.19% |
| Sept. 30, 2024 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Bernards Rene | Director | A | Options to Purchase Common Stock | 5304 | $0.00 | 19,453.0000 | 1,915,838 | 37.49% | 0.28% |
| June 30, 2024 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Bernards Rene | Director | A | Options to Purchase Common Stock | 10000 | $0.00 | 10,000.0000 | 1,915,838 | 9999.99% | 0.52% |
| June 30, 2024 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Bernards Rene | Director | A | Options to Purchase Common Stock | 4149 | $0.00 | 4,149.0000 | 1,915,838 | 9999.99% | 0.22% |
| Oct. 2, 2023 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Bernards Rene | Director | P | Common Stock | 4473 | $2.29 | 19,473.0000 | 0 | 29.82% | 0.00% |
| Oct. 3, 2023 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Bernards Rene | Director | P | Common Stock | 5527 | $2.51 | 25,000.0000 | 0 | 28.38% | 0.00% |
| Oct. 2, 2023 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Bernards Rene | Director | P | Common Stock | 4473 | $2.29 | 19,472.0000 | 0 | 29.82% | 0.00% |
| Oct. 3, 2023 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Bernards Rene | Director | P | Common Stock | 5527 | $2.51 | 20,000.0000 | 0 | 38.19% | 0.00% |